"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the ...

A growing body of research suggests that regular coffee drinking can lower the risk for liver, endometrial, and colorectal ...

Cancer is swiftly becoming a major health issue in India, affecting both urban and rural populations due to various factors.

Canaccord Genuity maintained a Buy rating on Natera (NASDAQ:NTRA) shares, with a price target of $180. Trading at $169.27, the $22.35 billion market cap company enjoys strong analyst support, with a ...

Natera (NTRA) commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice ...

The panelist discusses how, when discussing first-line treatment decisions for cancer patients, healthcare professionals primarily consider patient-specific factors like disease stage, molecular ...

Radiopharm Theranostics’ RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a ...

Nanotechnology, a groundbreaking field that involves manipulating matter at the molecular and atomic levels, is rapidly ...